The United States non-invasive aesthetic treatment market size surpassed USD 13.7 billion in 2025 and is predicted to reach around USD 26.95 billion by 2035, registering a CAGR of 7% from 2026 to 2035. The market is driven by high awareness, and people are willing to spend on appearance enhancement procedures.

U.S. Non-Invasive Aesthetic Treatment Market Statical Scope

The non-invasive treatments, such as botulinum toxin injections, dermal fillers, and skin rejuvenation procedures, are widely performed to enhance appearance. The country has a strong regulatory framework that ensures product safety and encourages innovation. The trends and continuous product launches influenced by celebrity culture keep demand high and make the United States a trendsetter in aesthetic medicine.

U.S. Non-Invasive Aesthetic Treatment Market Share, By Type, 2025, (%)

• Injectables - Injectables dominate the segment, with a share of 72%, driven by high consumer demand for minimally invasive procedures such as Botox and dermal fillers, along with quick results and minimal downtime.
• Skin Rejuvenation - Skin Rejuvenation holds a significant portion, with a share of 20%, supported by growing interest in non-invasive treatments for improving skin texture, tone, and anti-ageing benefits.
• Others - Others account for a smaller share, with a share of 8%, driven by niche and emerging aesthetic procedures that have comparatively lower adoption rates.

U.S. Non-Invasive Aesthetic Treatment Market Share, By End-Use, 2025, (%)

• Hospital / Surgery Centre - Hospital/Surgery Center holds a significant portion, with a share of 28%, supported by the availability of advanced equipment, skilled professionals, and higher trust for clinical-grade procedures.
• MedSpa - MedSpa leads the segment, with a share of 36%, driven by increasing consumer preference for specialized aesthetic services, personalized treatments, and a spa-like experience combined with medical expertise.
• Traditional Spa – Traditional Spa represents a smaller segment, with a share of 12%, constrained by limited medical-grade offerings and lower adoption for advanced aesthetic procedures.
• HCP Owned Clinic - HCP Owned Clinic accounts for a notable share, with a share of 24%, driven by direct access to certified healthcare professionals and growing demand for safe and regulated aesthetic treatments.

Top Companies in the U.S. Non-Invasive Aesthetic Treatment Market

• Hologic, Inc.
• Allergan, Inc.
• Galderma S.A.
• Alma Lasers
• Syneron Candela
• Johnson & Johnson
• MerzPharma
• Lumenis
• Solta Medical
• Cutera Inc.
• Revance Therapeutics Inc.

Segments Covered in the Report

By Procedure

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
  • Other Skin Rejuvenation Procedures
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

By End Use

• Hospital/Surgery Center
• MedSpa
• Traditional Spa
• HCP owned clinic